{"id":"W3009108936","doi":"10.3747/co.27.5933","title":"Systemic Adjuvant Therapy for Adult Patients at High Risk for Recurrent Cutaneous or Mucosal Melanoma: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline","year":2020,"lang":"en","type":"article","venue":"Current Oncology","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Kingston General Hospital; Health Sciences Centre; Ottawa Hospital; University of Ottawa; Queen's University; Grand River Hospital; Juravinski Hospital; Cancer Care Ontario; McMaster University; Credit Valley Hospital; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Dabrafenib; Ipilimumab; Pembrolizumab; Nivolumab; Melanoma; Trametinib; Guideline; Internal medicine; Oncology; Cancer; Adjuvant therapy; Mucosal melanoma; Dermatology; Immunotherapy; Vemurafenib; Pathology; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005234069,0.0004352656,0.001287263,0.00009554882,0.0003118852,0.00002594964,0.0002342137,0.0002637366,0.0004553391],"category_scores_gemma":[0.001090343,0.0003409816,0.0003599378,0.0001216988,0.00006819946,0.00009080982,0.0001247646,0.0006743456,0.00003427645],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006041077,"about_ca_system_score_gemma":0.002802176,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02956479,"about_ca_topic_score_gemma":0.5978757,"domain_scores_codex":[0.9957255,0.0004043743,0.00173694,0.001064082,0.0004174784,0.0006515979],"domain_scores_gemma":[0.9952114,0.0005094173,0.001189721,0.0004524097,0.001900183,0.000736922],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05709995,0.002954796,0.0387616,0.000734825,0.0004586408,0.00007720203,0.008336817,0.00002737537,0.00000800712,0.00006752996,0.1064831,0.7849901],"study_design_scores_gemma":[0.01772581,0.05295084,0.002318424,0.0001587462,0.0006119611,0.0002623029,0.001471245,0.0006737739,0.00001045787,0.00001068609,0.923464,0.0003417348],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9491471,0.004710794,0.003105236,0.01286885,0.0163626,0.01254191,0.0007937957,0.0002867655,0.0001829302],"genre_scores_gemma":[0.9021434,0.01292013,0.02754894,0.03684199,0.007101816,0.004477253,0.006624932,0.00032435,0.002017156],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8169809,"threshold_uncertainty_score":0.9999042,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1120385506817287,"score_gpt":0.4392480465217246,"score_spread":0.3272094958399958,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}